Cardura Xl

Active Ingredient(s): Doxazosin Mesylate
FDA Approved: * February 22, 2005
Pharm Company: * PFIZER
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cardura Xl Overview

Doxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura and Carduran, is an α1-selective alpha blocker used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia (BPH). Contents 1 Antihypertensive 2 Benign prostatic hypertrophy 3 Launch 4 References 5 External links Antihypertensive Doxazosin is usually added to other antihypertensive therapy such as calcium channel antagonists, diuretics, beta-adrenorecep...

Read more Cardura Xl Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Doxazosin

Recent Cardura Xl Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Cardura Xl: (2 results)

Sorted by National Drug Code

• 0049-2710 24 Hr Cardura 4 mg Extended Release Tablet by Roerig
• 0049-2720 24 Hr Cardura 8 mg Extended Release Tablet by Roerig

Other drugs which contain Doxazosin Mesylate or a similar ingredient: (2 results)

• CARDURA Doxazosin1 discussion
• DOXAZOSIN Doxazosin Mesylate35 discussions

Related Cardura Xl Topics: